Physiomics Expects Annual Loss To Be "Materially Reduced"
LONDON (Alliance News) - Physiomics PLC said Thursday it is trading "ahead of market expectations" for its financial year to the end of June.The company, which provides technology
Read moreFri, 06th Jan 2017 12:28
LONDON (Alliance News) - Physiomics PLC said Thursday it is trading "ahead of market expectations" for its financial year to the end of June.The company, which provides technology
Read moreLONDON (Alliance News) - Physiomics PLC on Wednesday said that it raised GBP525,000 through share placing to grow the business and expand its client base.The biotechnology company issued at
Read moreLONDON (Alliance News) - Physiomics PLC said Wednesday it has been awarded a new Innovate UK Grant worth GBP68,000 for a prostate cancer -
Read moreLONDON (Alliance News) - Physiomics PLC said Monday it has successfully completed the Innovate UK grant cancer treatment project, receiving in funding the
Read more(ShareCast News) - Physiomics announced on Wednesday that it is making good progress towards the strategic objectives announced in its most recent full year results, posted on 27 October 2016. The AIM-traded firm announced an initial payment by Sareum on 5 December, for modelling carried out by the
Read more(ShareCast News) - AIM listed Physiomics has called off its BioMoti acquisition after investors instead backed plans to develop its modelling and simulation business with a £555,000 discounted fundraising. Physiomics, which develops software to help drug companies predict and understand cancer drug
Read more(ShareCast News) - Physiomics had a new man at the helm on Monday, confirming Dr James Millen was taking the reins as CEO with immediate effect. The AIM-traded company said Millen, known as Jim, brought experience of drug development and licensing deals in global pharmaceutical companies with him.
Read more